Anticorps Anti - CDA (center )produit dans une solution aqueuse tamponnée à base de lapin, de sulfate d'ammonium saturé (SAS)

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.Immunofluorescence (1 paper)

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

CDA forms a homotetramer that catalyzes the irreversible hydrolytic deamination of cytidine and deoxycytidine to uridine and deoxyuridine, respectively. This protein is one of several deaminases responsible for maintaining the cellular pyrimidine pool. Mutations in the CDA gene are associated with decreased sensitivity to the cytosine nucleoside analogue cytosine arabinoside used in the treatment of certain childhood leukemias.

Immunogen

CDA (NP_001776, 55-93)This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the Center region of human CDA.

Physical form

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide.